CANCER AND LEUKEMIA GROUP B: RPMI/SUNYAB

癌症和白血病 B 组：RPMI/SUNYAB

• 批准号: 3555692
• 负责人: EDWARD S. HENDERSON
• 金额: $ 12.61万
• 依托单位: ROSWELL PARK CANCER INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1979
• 资助国家: 美国
• 起止时间: 1979-04-01 至 1989-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3555692
• 关键词: 6 thioguanine; Hodgkin's disease; asparaginase; bleomycin; blood transfusion; breast neoplasms; cancer information system; cell growth regulation; chemical structure function; child (0-11); cooperative study; cyclophosphamide; cytosine arabinoside; daunorubicin; dexamethasone; dosage; doxorubicin; drug adverse effect; fluorouracil; gastrointestinal neoplasms; granulocyte; human subject; human therapy evaluation; immunologic assay /test; immunosuppression; lomustine; lymphocytic leukemia; lymphoma; metastasis; methotrexate; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer classification /staging; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; nitrogen mustard; pediatric neoplasm /cancer; piperazines; platelet transfusion; platinum; prednisone; radiation therapy dosage; radioimmunoassay; spectrometry; steroids; thrombocytopenia; vinblastine; vincristine

This grant requests funds to support patient care activities, data collection, information exchange, and meeting travel for physicians participating in CALGB Group activities at Roswell Park Memorial Institute and the State University of New York at Buffalo. Participants represent medicine, surgery, radiation therapy, pathology, immunology, psychiatry, pharmacology, nursing, and data management specialties who will jointly evaluate new approaches to clinical cancer management as part of the cooperative Group program. Support for the participation of private practitioners in oncology is also sought through this grant, as are resources for extensive quality control activities for the primary and affiliate institutions.

该赠款请求资金支持患者护理活动、数据 医生收集、信息交流和会议旅行 参加罗斯威尔公园纪念研究所的 CALGB 小组活动 和纽约州立大学布法罗分校。 参加者代表 医学、外科、放射治疗、病理学、免疫学、精神病学、 药理学、护理学和数据管理专业人士将共同 评估临床癌症管理的新方法，作为 合作团体计划。 支持私人参与 还通过这笔赠款寻找肿瘤学从业者， 用于初级和中级广泛质量控制活动的资源 附属机构。

项目成果

Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.

比生群治疗非小细胞肺癌：癌症和白血病 B 组的 II 期试验。

• 发表时间: 1986
• 期刊: Cancer treatment reports
• 作者: Green,MR;Vosika,G;Propert,KJ;Ware,JH;Comis,R
• 通讯作者: Comis,R

Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease.

卡介苗甲醇提取残渣对晚期霍奇金病的作用。

• DOI: 10.1002/1097-0142(19820601)49:11<2226::aid-cncr2820491104>3.0.co;2-r
• 发表时间: 1982
• 期刊: Cancer
• 影响因子: 6.2
• 作者: Cooper,MR;Pajak,TF;Nissen,NI;Brunner,K;Stutzman,L;Bank,A;Falkson,G;Barker,BE;Haurani,FI;Richards2nd,F;Gottlieb,A;Holland,JF
• 通讯作者: Holland,JF

Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.

对马法兰耐药的多发性骨髓瘤：用阿霉素、环磷酰胺、卡莫司汀 (BCNU) 和泼尼松治疗。

• 发表时间: 1982
• 期刊: Cancer treatment reports
• 作者: Kyle,RA;Pajak,TF;Henderson,ES;Nawabi,IU;Brunner,K;Henry,PH;McIntyre,OR;Holland,JF
• 通讯作者: Holland,JF

Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.

广泛性霍奇金病的强化治疗：对已知疾病进行放射治疗或延长诱导化疗并不能提高生存率——癌症和白血病 B 组研究的结果。

• DOI: 10.1016/s0360-3016(98)00071-6
• 发表时间: 1998
• 期刊: International journal of radiation oncology, biology, physics
• 作者: Coleman,M;Rafla,S;Propert,KJ;Glicksman,A;Peterson,B;Nissen,N;Brunner,K;Holland,JF;Anderson,JR;Gottlieb,A;Kaufman,T
• 通讯作者: Kaufman,T

Terminal deoxynucleotidyl transferase activity and blast cell characteristics in adult acute leukemias.

成人急性白血病的末端脱氧核苷酸转移酶活性和母细胞特征。

• DOI: 10.1016/0145-2126(80)90080-6
• 发表时间: 1980
• 期刊: Leukemia research
• 影响因子: 2.7
• 作者: SahaiSrivastava,BI;Khan,SA;Minowada,J;Henderson,ES;Rakowski,I
• 通讯作者: Rakowski,I